SCM
IRON icon

Sterling Capital Management’s Disc Medicine IRON Stock Holding History

Sterling Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.24K Sell
99
-79
-44% -$5.43K ﹤0.01% 2408
2026
Q1 		$11.4K Buy
178
+15
+9% +$1.04K ﹤0.01% 2303
2025
Q4 		$12.9K Buy
163
+107
+191% +$9.04K ﹤0.01% 2479
2025
Q3 		$3.7K Sell
56
-4
-7% -$238 ﹤0.01% 2851
2025
Q2 		$3.18K Sell
60
-292
-83% -$13.7K ﹤0.01% 2756
2025
Q1 		$17.5K Sell
352
-214
-38% -$11.9K ﹤0.01% 1694
2024
Q4 		$35.9K Buy
566
+503
+798% +$29.1K ﹤0.01% 1707
2024
Q3 		$3.1K Buy
+63
New +$2.96K ﹤0.01% 1981

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sterling Capital Management's IRON Position: Q2 2026 in Review

Sterling Capital Management reduced its Disc Medicine (IRON) stake by 44% in Q2 2026, selling an estimated $5.43K and leaving 99 shares worth $7.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

Sterling Capital Management first reported a position in IRON in Q3 2024 and has held it in 8 quarters since. The position peaked at $35.9K in Q4 2024. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Sterling Capital Management held 99 shares of Disc Medicine worth $7.24K as of Q2 2026.
  • Sterling Capital Management sold 79 Disc Medicine shares in Q2 2026, an estimated $5.43K.
  • Disc Medicine made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2408 holding.
  • Sterling Capital Management first reported a position in Disc Medicine in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Disc Medicine position peaked at $35.9K in Q4 2024.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.